BCR-ABL1-IN-2
BCR-ABL1-IN-2 (compound 8) is a potent BCR-ABL1 tyrosine kinase inhibitor. BCR-ABL1-IN-2 exhibits activity in Imatinib (HY-15463) resistant K562/DOX cells with LC50 of 5.29 μM. BCR-ABL1-IN-2 shows no significant toxicity in nontumor cells. BCR-ABL1-IN-2 can be used for chronic myeloid leukemia research.
For research use only. We do not sell to patients.
- Formula: C35H35N7O
- Molecular Weight:569.70
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
BCR-ABL1 |
Chemical Information
-
Molecular Weight 569.70
-
Formula C35H35N7O
-
SMILES
O=C(C1=CC=C(C=C1)CN2CCC(C3=CC=C(C=C3)N)CC2)NC4=CC=C(C(NC5=NC=CC(C6=CC=CN=C6)=N5)=C4)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)